Association of Lymph Nodes Positive Rate With the Risk of Recurrence in Patients With Stage T1 Papillary Thyroid Cancer.

IF 3 Q2 ENDOCRINOLOGY & METABOLISM Journal of the Endocrine Society Pub Date : 2024-07-05 eCollection Date: 2024-07-01 DOI:10.1210/jendso/bvae131
Chao Qin, Sijia Cai, Min Yin, Ben Ma, Cenkai Shen, Yanzhi Zhang, Qinghai Ji, Tian Liao, Yu Wang
{"title":"Association of Lymph Nodes Positive Rate With the Risk of Recurrence in Patients With Stage T1 Papillary Thyroid Cancer.","authors":"Chao Qin, Sijia Cai, Min Yin, Ben Ma, Cenkai Shen, Yanzhi Zhang, Qinghai Ji, Tian Liao, Yu Wang","doi":"10.1210/jendso/bvae131","DOIUrl":null,"url":null,"abstract":"<p><p>The incidence of lymph node metastasis in papillary thyroid carcinoma (PTC) is common and a significant risk factor for local recurrence; however, its impact on recurrence patterns among low-risk patients remains uncertain. We aimed to elucidate the effect of metastatic lymph node on recurrence type. The medical records of 1209 patients with stage T1 PTC who underwent unilateral thyroidectomy with ipsilateral central lymph node dissection were retrospectively analyzed. The study first identified risk factors for different types of recurrence and then categorized patients as high or low risk based on their lymph node positive ratio (LNPR). The diagnostic accuracy of LNPR in predicting recurrence was compared using receiver operating characteristic (ROC) curve analysis, while differences in recurrence-free survival were assessed using the Kaplan-Meier method. During follow-up, a total of 502 (41.5%) patients had central lymph node metastasis and 52 (4.3%) patients experienced recurrence. Notably, LNPR was significantly higher in relapsed patients compared to nonrelapsed patients, with mean values of 0.45 and 0.23, respectively (<i>P</i> < .001). The recurrence rate of residual thyroid did not differ significantly across different T stages (<i>P</i> = .679), N stages (<i>P</i> = .415), or LNPR risk groups (<i>P</i> = .175). However, the recurrence rate of lymph nodes showed a significant correlation with LNPR (<i>P</i> < .001). The area under the ROC curves for LNPR risk stratification at 5 and 10 years were approximately 0.691 and 0.634, respectively, both of which outperformed N stage. The findings underscore the significance of LNPR's reliability as a prognostic indicator for local lymph node recurrence in patients diagnosed with T1 stage PTC.</p>","PeriodicalId":17334,"journal":{"name":"Journal of the Endocrine Society","volume":"8 8","pages":"bvae131"},"PeriodicalIF":3.0000,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11250184/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Endocrine Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1210/jendso/bvae131","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

The incidence of lymph node metastasis in papillary thyroid carcinoma (PTC) is common and a significant risk factor for local recurrence; however, its impact on recurrence patterns among low-risk patients remains uncertain. We aimed to elucidate the effect of metastatic lymph node on recurrence type. The medical records of 1209 patients with stage T1 PTC who underwent unilateral thyroidectomy with ipsilateral central lymph node dissection were retrospectively analyzed. The study first identified risk factors for different types of recurrence and then categorized patients as high or low risk based on their lymph node positive ratio (LNPR). The diagnostic accuracy of LNPR in predicting recurrence was compared using receiver operating characteristic (ROC) curve analysis, while differences in recurrence-free survival were assessed using the Kaplan-Meier method. During follow-up, a total of 502 (41.5%) patients had central lymph node metastasis and 52 (4.3%) patients experienced recurrence. Notably, LNPR was significantly higher in relapsed patients compared to nonrelapsed patients, with mean values of 0.45 and 0.23, respectively (P < .001). The recurrence rate of residual thyroid did not differ significantly across different T stages (P = .679), N stages (P = .415), or LNPR risk groups (P = .175). However, the recurrence rate of lymph nodes showed a significant correlation with LNPR (P < .001). The area under the ROC curves for LNPR risk stratification at 5 and 10 years were approximately 0.691 and 0.634, respectively, both of which outperformed N stage. The findings underscore the significance of LNPR's reliability as a prognostic indicator for local lymph node recurrence in patients diagnosed with T1 stage PTC.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
T1期乳头状甲状腺癌患者淋巴结阳性率与复发风险的关系
淋巴结转移在甲状腺乳头状癌(PTC)中很常见,也是局部复发的一个重要风险因素;然而,淋巴结转移对低风险患者复发模式的影响仍不确定。我们旨在阐明转移淋巴结对复发类型的影响。我们对 1209 例接受单侧甲状腺切除术并同侧中央淋巴结清扫术的 T1 期 PTC 患者的病历进行了回顾性分析。研究首先确定了不同类型复发的风险因素,然后根据淋巴结阳性率(LNPR)将患者分为高危和低危。采用接收器操作特征曲线(ROC)分析比较了淋巴结阳性率在预测复发方面的诊断准确性,并采用卡普兰-梅耶法评估了无复发生存率的差异。随访期间,共有 502 例(41.5%)患者出现中心淋巴结转移,52 例(4.3%)患者复发。值得注意的是,复发患者的淋巴结转移率明显高于未复发患者,平均值分别为0.45和0.23(P < .001)。残留甲状腺的复发率在不同的T分期(P = .679)、N分期(P = .415)或LNPR风险组别(P = .175)之间没有明显差异。但是,淋巴结复发率与 LNPR 呈显著相关性(P < .001)。5 年和 10 年 LNPR 风险分层的 ROC 曲线下面积分别约为 0.691 和 0.634,均优于 N 分期。这些发现强调了 LNPR 作为确诊为 T1 期 PTC 患者的局部淋巴结复发预后指标的可靠性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of the Endocrine Society
Journal of the Endocrine Society Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
5.50
自引率
0.00%
发文量
2039
审稿时长
9 weeks
期刊最新文献
A Stronger IMPACT on Career Development for Early- and Mid-career Faculty. Blood Pressure Decreases in Overweight Elderly Individuals on Vitamin D: A Randomized Trial. Aromatase Inhibitor Monotherapy to Augment Height in Boys: Does It Work and Is It Safe? Innovative Glucagon-based Therapies for Obesity. Efficacy of Tocilizumab in Refractory Graves Orbitopathy From Real-World Clinical Practice: An Observational Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1